Medtronic’s (NYSE:MDT) India-based subsidiary announced a strategic partnership with Stasis Health and its bedside monitoring system.
India Medtronic Private Limited and Stasis Health (a wholly-owned subsidiary of Stasis Labs) partnered to scale up and expand access to the Stasis Monitor, a connected care bedside multi-parameter monitoring system, according to a news release.
The Stasis Monitor, which uses patented predictive artificial intelligence, holds FDA clearance for automating and digitizing monitoring, documentation and communication of critical patient information. Medtronic believes the addition of the platform to its portfolio expands its ability to serve patients inside the hospital while offering physicians the option to remotely monitor their patients.
Available for use in emergency ICUs, surgical ICUs, high-dependency units, step-down units and private patient rooms, the Stasis Monitor system includes a bedside monitor that monitors…